Psoralen alleviates high glucose-induced HK-2 cell injury by inhibition of Smad 2 signaling via upregulation of microRNA 874.

BMC Pharmacology & Toxicology
Yongtao LinDonghui Zheng

Abstract

Diabetic nephropathy (DN) causes the vast proportion of excess mortality for patients with diabetes. Novel therapeutic approaches slowing down its incidence is still lacking. Psoralen is the major active ingredient of Psoralea corylifolia Linn. (PCL), which was used to treat a number of diseases. In this study, we aimed to investigate whether psoralen could alleviate DN using in vitro model. Cell viability assay and immunofluorescence were used to evaluate the effect of psoralen on high glucose (HG)-stimulated human kidney HK-2 cells (48 h). RT-qPCR was used to detect the expressions of miRNA in cells. Cell transfection, apoptosis assay, inflammatory cytokines detection and Western blot were further performed to explore the underlying molecular mechanisms. HG-induced toxicity of HK-2 cells was alleviated by psoralen. Meanwhile, the secretion of inflammatory cytokines and extracellular matrix (ECM) accumulation induced by HG in HK-2 cells were also decreased by psoralen. In addition, the expression of miR-874 in HK-2 cells was significantly upregulated by psoralen. Western blot assays indicated that psoralen could reverse HG-induced increase of TLR-4/NF-κB and Smad2 via upregulation of miR-874. This study demonstrated that psora...Continue Reading

References

Jan 12, 2011·Biochemical and Biophysical Research Communications·De-Zhi TangYong-Jun Wang
Jan 31, 2013·Journal of the American Society of Nephrology : JASN·Maryam AfkarianIan H de Boer
Jul 9, 2013·Fitoterapia·Bhawna ChopraKanaya Lal Dhar
Aug 2, 2014·Transplant International : Official Journal of the European Society for Organ Transplantation·Sokratis StoumposPatrick B Mark
Jun 13, 2015·Journal of Diabetes Research·Stephanie Toth-Manikowski, Mohamed G Atta
Dec 18, 2015·The Review of Diabetic Studies : RDS·Konstantinos Tziomalos, Vasilios G Athyros
Dec 3, 2016·Journal of Experimental & Clinical Cancer Research : CR·Xiaohong WangZhenlin Yang
Jan 5, 2017·The Korean Journal of Internal Medicine·Yaeni Kim, Cheol Whee Park
Mar 30, 2017·BioMed Research International·Shuqing ChenXinlin Wu
Sep 28, 2017·International Journal of Molecular Medicine·Wenwei ZhengHongzhi Ye
Sep 29, 2017·Cardiovascular Drugs and Therapy·Corey MageeDerek P Brazil
Dec 19, 2017·Frontiers in Pharmacology·Lishan ZhouSuqi Yan
Jun 26, 2018·Biochemical Pharmacology·Saikat Dewanjee, Niloy Bhattacharjee
Aug 20, 2018·Molecular Therapy. Nucleic Acids·Juan WangDongshan Zhang
Oct 23, 2018·Pharmaceutical Biology·Yuzhu ZhangHongfeng Chen
Jan 4, 2019·Roczniki Państwowego Zakładu Higieny·Klaudia NadolnikPawe Bogdański
Sep 6, 2019·International Journal of Molecular Medicine·Nan LiJiang-Yi Yu
Nov 30, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Luna GeJinxiang Han
May 15, 2020·Iranian Journal of Basic Medical Sciences·Xin-Feng LinWei-Tao Chen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
transfections
PCR
flow cytometry
electrophoresis
transfection

Software Mentioned

GraphPad Prism
ImageJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis